We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Taste for blood

19 Jun 2018 By Pete Sweeney

The plasma products maker received a $3.7 bln takeover bid from the Beijing-based bank’s buyout arm. CITIC offered a healthy 34 pct premium. It could capitalize on a market shakeout, but it’s hard to be sanguine about infusing a company with debt amid risky regulatory upheaval.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)